Advertisement

Index by author

June 01, 1989; Volume 249,Issue 3

A

  1. Abe, A

    1. Effect of forskolin on cytosolic Ca++ level and contraction in vascular smooth muscle.
      A Abe and H Karaki
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 895-900;

  2. Adrian, T E

    1. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
      A J Bean, T E Adrian, I M Modlin and R H Roth
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 681-687;

  3. Alberts, D W

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

  4. Andon, N

    1. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
      J Loscalzo, D Smick, N Andon and J Cooke
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 726-729;
    2. S-nitrosocaptopril. II. Effects on vascular reactivity.
      J P Cooke, N Andon and J Loscalzo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 730-734;

  5. Appel, N M

    1. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies.
      N M Appel, J F Contrera and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 928-943;

  6. Atchison, W D

    1. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
      W D Atchison
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 735-743;

B

  1. Balster, R L

    1. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
      R L Balster
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 749-756;

  2. Battaglia, G

    1. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
      T R Insel, G Battaglia, J N Johannessen, S Marra and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 713-720;

  3. Bean, A J

    1. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
      A J Bean, T E Adrian, I M Modlin and R H Roth
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 681-687;

  4. Bickers, D R

    1. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat.
      W A Khan, S S Park, H V Gelboin, D R Bickers and H Mukhtar
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 921-927;

  5. Black, A C

    1. Changes in the muscarinic cholinergic receptors in the hippocampus of rats exposed to ethyl alcohol during the brain growth spurt.
      S J Kelly, A C Black and J R West
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 798-804;

  6. Booze, R M

    1. Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig.
      R M Booze, E A Crisostomo and J N Davis
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 911-920;

  7. Braakman, I

    1. Zonal compartmentation of perfused rat liver: plasma reappearance of rhodamine B explained.
      I Braakman, G M Groothuis and D K Meijer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 869-873;

  8. Bragdon, A C

    1. Baclofen has a proepileptic effect in the rat dentate gyrus.
      D D Mott, A C Bragdon, D V Lewis and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 721-725;

  9. Brase, D A

    1. Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.
      F Lux, Y H Han, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 688-693;

  10. Breimer, D D

    1. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
      J B van Bree, A G de Boer, J C Verhoef, M Danhof and D D Breimer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 901-905;

  11. Bugelski, P J

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

C

  1. Canning, B

    1. Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.
      L Noronha-Blob, V Lowe, A Patton, B Canning, D Costello and W J Kinnier
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 843-851;

  2. Chiodo, L A

    1. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
      A S Freeman, M D Kelland, C Rouillard and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 790-797;

  3. Chipkin, R E

    1. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
      V L Coffin, M B Latranyi and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 769-774;

  4. Coffin, V L

    1. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
      V L Coffin, M B Latranyi and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 769-774;

  5. Contrera, J F

    1. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies.
      N M Appel, J F Contrera and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 928-943;

  6. Cooke, J

    1. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
      J Loscalzo, D Smick, N Andon and J Cooke
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 726-729;

  7. Cooke, J P

    1. S-nitrosocaptopril. II. Effects on vascular reactivity.
      J P Cooke, N Andon and J Loscalzo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 730-734;

  8. Costello, D

    1. Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.
      L Noronha-Blob, V Lowe, A Patton, B Canning, D Costello and W J Kinnier
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 843-851;

  9. Coyle, J T

    1. Specificity of the activation of [3H]hemicholinium-3 binding by phospholipase A2.
      K Yamada, M D Saltarelli and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 836-842;

  10. Cragoe, E J

    1. Synergistic alpha-1 and alpha-2 adrenergic stimulation of rat proximal nephron Na+/H+ exchange.
      F A Gesek, E J Cragoe and J W Strandhoy
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 694-700;

  11. Crisostomo, E A

    1. Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig.
      R M Booze, E A Crisostomo and J N Davis
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 911-920;

D

  1. Danhof, M

    1. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
      J B van Bree, A G de Boer, J C Verhoef, M Danhof and D D Breimer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 901-905;

  2. Davis, J N

    1. Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig.
      R M Booze, E A Crisostomo and J N Davis
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 911-920;

  3. de Boer, A G

    1. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
      J B van Bree, A G de Boer, J C Verhoef, M Danhof and D D Breimer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 901-905;

  4. Deisher, T A

    1. Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age.
      T A Deisher, S Mankani and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 812-819;

  5. Desiderio, D

    1. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
      G M Rubanyi, D Desiderio, A Luisi, A Johns and E J Sybertz
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 858-863;

  6. De Souza, E B

    1. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
      T R Insel, G Battaglia, J N Johannessen, S Marra and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 713-720;
    2. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies.
      N M Appel, J F Contrera and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 928-943;

  7. Deutsch, S I

    1. Repeated swim stress alters brain benzodiazepine receptors measured in vivo.
      R Weizman, A Weizman, K A Kook, F Vocci, S I Deutsch and S M Paul
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 701-707;

  8. Dewey, W L

    1. Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.
      F Lux, Y H Han, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 688-693;

E

  1. Eckardt, R D

    1. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
      E F Smith, M J Slivjak, R D Eckardt and J F Newton
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 805-811;

F

  1. Freeman, A S

    1. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
      A S Freeman, M D Kelland, C Rouillard and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 790-797;

  2. Fujimoto, J M

    1. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
      S C Roerig and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 762-768;

G

  1. Gelboin, H V

    1. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat.
      W A Khan, S S Park, H V Gelboin, D R Bickers and H Mukhtar
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 921-927;

  2. Gesek, F A

    1. Synergistic alpha-1 and alpha-2 adrenergic stimulation of rat proximal nephron Na+/H+ exchange.
      F A Gesek, E J Cragoe and J W Strandhoy
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 694-700;

  3. Goldstein, J M

    1. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.
      J M Goldstein, L C Litwin, E B Sutton and J B Malick
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 673-680;

  4. Groothuis, G M

    1. Zonal compartmentation of perfused rat liver: plasma reappearance of rhodamine B explained.
      I Braakman, G M Groothuis and D K Meijer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 869-873;

H

  1. Hamel, E

    1. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
      E Hamel, J P Robert, A R Young and E T MacKenzie
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 879-889;

  2. Han, Y H

    1. Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.
      F Lux, Y H Han, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 688-693;

  3. Harik, S I

    1. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
      N J Riachi, J C LaManna and S I Harik
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 744-748;

  4. Heijna, M H

    1. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
      M H Heijna, F Hogenboom, P S Portoghese, A H Mulder and A N Schoffelmeer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 864-868;

  5. Heikkila, R E

    1. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
      S K Youngster, P K Sonsalla, B A Sieber and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 820-828;
    2. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
      S K Youngster, W J Nicklas and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 829-835;

  6. Hoffman, B B

    1. Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age.
      T A Deisher, S Mankani and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 812-819;

  7. Hogenboom, F

    1. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
      M H Heijna, F Hogenboom, P S Portoghese, A H Mulder and A N Schoffelmeer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 864-868;

  8. Hoke, G D

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

I

  1. Insel, T R

    1. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
      T R Insel, G Battaglia, J N Johannessen, S Marra and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 713-720;

J

  1. Jacobson, A E

    1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
      M A Rogawski, A Thurkauf, S Yamaguchi, K C Rice, A E Jacobson and M V Mattson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 708-712;

  2. Johannessen, J N

    1. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
      T R Insel, G Battaglia, J N Johannessen, S Marra and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 713-720;

  3. Johns, A

    1. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
      G M Rubanyi, D Desiderio, A Luisi, A Johns and E J Sybertz
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 858-863;

K

  1. Kalsner, S

    1. Cholinergic contraction to field stimulation in coronary arteries of cattle.
      S Kalsner and M Quillan
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 785-789;

  2. Kamata, K

    1. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats.
      K Kamata, N Miyata and Y Kasuya
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 890-894;

  3. Karaki, H

    1. Effect of forskolin on cytosolic Ca++ level and contraction in vascular smooth muscle.
      A Abe and H Karaki
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 895-900;

  4. Kasuya, Y

    1. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats.
      K Kamata, N Miyata and Y Kasuya
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 890-894;

  5. Kelland, M D

    1. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
      A S Freeman, M D Kelland, C Rouillard and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 790-797;

  6. Kelly, S J

    1. Changes in the muscarinic cholinergic receptors in the hippocampus of rats exposed to ethyl alcohol during the brain growth spurt.
      S J Kelly, A C Black and J R West
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 798-804;

  7. Khan, W A

    1. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat.
      W A Khan, S S Park, H V Gelboin, D R Bickers and H Mukhtar
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 921-927;

  8. Kinnier, W J

    1. Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.
      L Noronha-Blob, V Lowe, A Patton, B Canning, D Costello and W J Kinnier
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 843-851;

  9. Kirchner, K A

    1. Role of medullary plasma flow in the attenuated furosemide response in indomethacin-treated rats.
      K A Kirchner
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 757-761;

  10. Kook, K A

    1. Repeated swim stress alters brain benzodiazepine receptors measured in vivo.
      R Weizman, A Weizman, K A Kook, F Vocci, S I Deutsch and S M Paul
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 701-707;

  11. Kuipers, F

    1. Stereoselectivity of glutathione conjugation: blood elimination of alpha-bromoisovalerylurea enantiomers and biliary excretion of the conjugates in unanesthetized normal or congenitally jaundiced rats.
      M Polhuijs, F Kuipers, R J Vonk and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 874-878;

  12. Kurtzman, N A

    1. Dimethyl sulfoxide affects water flow through a nonosmolar action.
      S Sabatini, J C Wharton, H K Lim and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 852-857;

L

  1. LaManna, J C

    1. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
      N J Riachi, J C LaManna and S I Harik
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 744-748;

  2. Latranyi, M B

    1. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
      V L Coffin, M B Latranyi and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 769-774;

  3. Lewis, D V

    1. Baclofen has a proepileptic effect in the rat dentate gyrus.
      D D Mott, A C Bragdon, D V Lewis and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 721-725;

  4. Liang, B T

    1. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.
      B T Liang
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 775-784;

  5. Lim, H K

    1. Dimethyl sulfoxide affects water flow through a nonosmolar action.
      S Sabatini, J C Wharton, H K Lim and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 852-857;

  6. Litwin, L C

    1. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.
      J M Goldstein, L C Litwin, E B Sutton and J B Malick
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 673-680;

  7. Loscalzo, J

    1. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
      J Loscalzo, D Smick, N Andon and J Cooke
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 726-729;
    2. S-nitrosocaptopril. II. Effects on vascular reactivity.
      J P Cooke, N Andon and J Loscalzo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 730-734;

  8. Lowe, V

    1. Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.
      L Noronha-Blob, V Lowe, A Patton, B Canning, D Costello and W J Kinnier
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 843-851;

  9. Luisi, A

    1. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
      G M Rubanyi, D Desiderio, A Luisi, A Johns and E J Sybertz
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 858-863;

  10. Lupo, S

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

  11. Lux, F

    1. Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.
      F Lux, Y H Han, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 688-693;

M

  1. MacKenzie, E T

    1. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
      E Hamel, J P Robert, A R Young and E T MacKenzie
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 879-889;

  2. Malick, J B

    1. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.
      J M Goldstein, L C Litwin, E B Sutton and J B Malick
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 673-680;

  3. Mankani, S

    1. Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age.
      T A Deisher, S Mankani and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 812-819;

  4. Marra, S

    1. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
      T R Insel, G Battaglia, J N Johannessen, S Marra and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 713-720;

  5. Mattson, M V

    1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
      M A Rogawski, A Thurkauf, S Yamaguchi, K C Rice, A E Jacobson and M V Mattson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 708-712;

  6. Meijer, D K

    1. Zonal compartmentation of perfused rat liver: plasma reappearance of rhodamine B explained.
      I Braakman, G M Groothuis and D K Meijer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 869-873;

  7. Mirabelli, C K

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

  8. Miyata, N

    1. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats.
      K Kamata, N Miyata and Y Kasuya
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 890-894;

  9. Modlin, I M

    1. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
      A J Bean, T E Adrian, I M Modlin and R H Roth
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 681-687;

  10. Mott, D D

    1. Baclofen has a proepileptic effect in the rat dentate gyrus.
      D D Mott, A C Bragdon, D V Lewis and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 721-725;

  11. Mukhtar, H

    1. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat.
      W A Khan, S S Park, H V Gelboin, D R Bickers and H Mukhtar
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 921-927;

  12. Mulder, A H

    1. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
      M H Heijna, F Hogenboom, P S Portoghese, A H Mulder and A N Schoffelmeer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 864-868;

  13. Mulder, G J

    1. Stereoselectivity of glutathione conjugation: blood elimination of alpha-bromoisovalerylurea enantiomers and biliary excretion of the conjugates in unanesthetized normal or congenitally jaundiced rats.
      M Polhuijs, F Kuipers, R J Vonk and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 874-878;

N

  1. Newton, J F

    1. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
      E F Smith, M J Slivjak, R D Eckardt and J F Newton
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 805-811;

  2. Nicklas, W J

    1. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
      S K Youngster, W J Nicklas and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 829-835;

  3. Noronha-Blob, L

    1. Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.
      L Noronha-Blob, V Lowe, A Patton, B Canning, D Costello and W J Kinnier
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 843-851;

P

  1. Park, S S

    1. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat.
      W A Khan, S S Park, H V Gelboin, D R Bickers and H Mukhtar
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 921-927;

  2. Patton, A

    1. Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.
      L Noronha-Blob, V Lowe, A Patton, B Canning, D Costello and W J Kinnier
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 843-851;

  3. Paul, S M

    1. Repeated swim stress alters brain benzodiazepine receptors measured in vivo.
      R Weizman, A Weizman, K A Kook, F Vocci, S I Deutsch and S M Paul
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 701-707;

  4. Polhuijs, M

    1. Stereoselectivity of glutathione conjugation: blood elimination of alpha-bromoisovalerylurea enantiomers and biliary excretion of the conjugates in unanesthetized normal or congenitally jaundiced rats.
      M Polhuijs, F Kuipers, R J Vonk and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 874-878;

  5. Portoghese, P S

    1. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
      M H Heijna, F Hogenboom, P S Portoghese, A H Mulder and A N Schoffelmeer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 864-868;

Q

  1. Quillan, M

    1. Cholinergic contraction to field stimulation in coronary arteries of cattle.
      S Kalsner and M Quillan
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 785-789;

R

  1. Riachi, N J

    1. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
      N J Riachi, J C LaManna and S I Harik
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 744-748;

  2. Rice, K C

    1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
      M A Rogawski, A Thurkauf, S Yamaguchi, K C Rice, A E Jacobson and M V Mattson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 708-712;

  3. Robert, J P

    1. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
      E Hamel, J P Robert, A R Young and E T MacKenzie
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 879-889;

  4. Roerig, S C

    1. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
      S C Roerig and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 762-768;

  5. Rogawski, M A

    1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
      M A Rogawski, A Thurkauf, S Yamaguchi, K C Rice, A E Jacobson and M V Mattson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 708-712;

  6. Roth, R H

    1. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
      A J Bean, T E Adrian, I M Modlin and R H Roth
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 681-687;

  7. Rouillard, C

    1. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
      A S Freeman, M D Kelland, C Rouillard and L A Chiodo
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 790-797;

  8. Rubanyi, G M

    1. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
      G M Rubanyi, D Desiderio, A Luisi, A Johns and E J Sybertz
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 858-863;

  9. Rush, G F

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

S

  1. Sabatini, S

    1. Dimethyl sulfoxide affects water flow through a nonosmolar action.
      S Sabatini, J C Wharton, H K Lim and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 852-857;

  2. Saltarelli, M D

    1. Specificity of the activation of [3H]hemicholinium-3 binding by phospholipase A2.
      K Yamada, M D Saltarelli and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 836-842;

  3. Schoffelmeer, A N

    1. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
      M H Heijna, F Hogenboom, P S Portoghese, A H Mulder and A N Schoffelmeer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 864-868;

  4. Schor, N F

    1. Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture.
      N F Schor
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 906-910;

  5. Sieber, B A

    1. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
      S K Youngster, P K Sonsalla, B A Sieber and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 820-828;

  6. Slivjak, M J

    1. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
      E F Smith, M J Slivjak, R D Eckardt and J F Newton
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 805-811;

  7. Smick, D

    1. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
      J Loscalzo, D Smick, N Andon and J Cooke
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 726-729;

  8. Smith, E F

    1. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
      E F Smith, M J Slivjak, R D Eckardt and J F Newton
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 805-811;

  9. Smith, P F

    1. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
      P F Smith, G D Hoke, D W Alberts, P J Bugelski, S Lupo, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 944-950;

  10. Sonsalla, P K

    1. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
      S K Youngster, P K Sonsalla, B A Sieber and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 820-828;

  11. Strandhoy, J W

    1. Synergistic alpha-1 and alpha-2 adrenergic stimulation of rat proximal nephron Na+/H+ exchange.
      F A Gesek, E J Cragoe and J W Strandhoy
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 694-700;

  12. Sutton, E B

    1. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.
      J M Goldstein, L C Litwin, E B Sutton and J B Malick
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 673-680;

  13. Sybertz, E J

    1. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
      G M Rubanyi, D Desiderio, A Luisi, A Johns and E J Sybertz
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 858-863;

T

  1. Thurkauf, A

    1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
      M A Rogawski, A Thurkauf, S Yamaguchi, K C Rice, A E Jacobson and M V Mattson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 708-712;

V

  1. van Bree, J B

    1. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
      J B van Bree, A G de Boer, J C Verhoef, M Danhof and D D Breimer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 901-905;

  2. Verhoef, J C

    1. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
      J B van Bree, A G de Boer, J C Verhoef, M Danhof and D D Breimer
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 901-905;

  3. Vocci, F

    1. Repeated swim stress alters brain benzodiazepine receptors measured in vivo.
      R Weizman, A Weizman, K A Kook, F Vocci, S I Deutsch and S M Paul
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 701-707;

  4. Vonk, R J

    1. Stereoselectivity of glutathione conjugation: blood elimination of alpha-bromoisovalerylurea enantiomers and biliary excretion of the conjugates in unanesthetized normal or congenitally jaundiced rats.
      M Polhuijs, F Kuipers, R J Vonk and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 874-878;

W

  1. Weizman, A

    1. Repeated swim stress alters brain benzodiazepine receptors measured in vivo.
      R Weizman, A Weizman, K A Kook, F Vocci, S I Deutsch and S M Paul
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 701-707;

  2. Weizman, R

    1. Repeated swim stress alters brain benzodiazepine receptors measured in vivo.
      R Weizman, A Weizman, K A Kook, F Vocci, S I Deutsch and S M Paul
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 701-707;

  3. West, J R

    1. Changes in the muscarinic cholinergic receptors in the hippocampus of rats exposed to ethyl alcohol during the brain growth spurt.
      S J Kelly, A C Black and J R West
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 798-804;

  4. Wharton, J C

    1. Dimethyl sulfoxide affects water flow through a nonosmolar action.
      S Sabatini, J C Wharton, H K Lim and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 852-857;

  5. Wilson, W A

    1. Baclofen has a proepileptic effect in the rat dentate gyrus.
      D D Mott, A C Bragdon, D V Lewis and W A Wilson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 721-725;

Y

  1. Yamada, K

    1. Specificity of the activation of [3H]hemicholinium-3 binding by phospholipase A2.
      K Yamada, M D Saltarelli and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 836-842;

  2. Yamaguchi, S

    1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
      M A Rogawski, A Thurkauf, S Yamaguchi, K C Rice, A E Jacobson and M V Mattson
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 708-712;

  3. Young, A R

    1. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
      E Hamel, J P Robert, A R Young and E T MacKenzie
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 879-889;

  4. Youngster, S K

    1. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
      S K Youngster, P K Sonsalla, B A Sieber and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 820-828;
    2. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
      S K Youngster, W J Nicklas and R E Heikkila
      Journal of Pharmacology and Experimental Therapeutics June 1989, 249 (3) 829-835;
Back to top

In this issue